8-K: KALA BIO Dismisses Deloitte as Independent Auditor

KALA BIO, Inc. announced the dismissal of Deloitte & Touche LLP as its independent registered public accounting firm, effective December 15, 2025.

Summary

• KALA BIO, Inc. (the Company) dismissed Deloitte & Touche LLP (Deloitte) as its independent registered public accounting firm.
• The dismissal was approved by the Audit Committee of the Board of Directors on December 15, 2025, and became effective on the same date.
• Deloitte's audit reports for the fiscal years ended December 31, 2024, and 2023, did not contain adverse opinions, disclaimers, or qualifications.
• There were no disagreements on accounting principles, financial statement disclosure, or auditing scope/procedure with Deloitte during the two most recent fiscal years and subsequent interim periods through December 15, 2025.
• No reportable events occurred during the specified periods.
• The Company has not yet appointed a new independent registered public accounting firm as of December 16, 2025.

Sentiment

Score: 5

Explanation: Neutral. The dismissal of an auditor without immediate replacement introduces some uncertainty, but the clean audit history with the previous firm and the absence of disagreements are positive indicators. This is a procedural change rather than a performance indicator.

Positives

• Deloitte's audit reports for the fiscal years ended December 31, 2024, and 2023, were clean, with no adverse opinions, disclaimers, or qualifications.
• No disagreements on accounting principles, financial statement disclosure, or auditing scope/procedure were reported with Deloitte.
• No reportable events were identified during the relevant periods.

Negatives

• The company has not yet appointed a new independent registered public accounting firm as of the filing date, which could lead to uncertainty or potential delays in future financial reporting.

Risks

• Potential for delays in future financial reporting if a new independent registered public accounting firm is not appointed in a timely manner.
• Uncertainty regarding the transition process to a new auditor and its potential impact on financial statement preparation and review.

Future Outlook

The company needs to appoint a new independent registered public accounting firm to ensure continuity and compliance with future financial reporting requirements.

Management Comments

• The Audit Committee of the Board of Directors of KALA BIO, Inc. approved the dismissal of Deloitte & Touche LLP as the Company's independent registered public accounting firm, effective as of December 15, 2025.
• The Company has not appointed a new independent registered public accounting firm as of the date of this filing.

Industry Context

Changes in independent auditors are common in the biotechnology industry, often driven by cost considerations, scope of services, or routine rotation policies. However, the lack of an immediate replacement can raise questions about the continuity of financial oversight and the potential for disruption in financial reporting processes.

Corporate Governance

Stakeholder Impact

• Shareholders: May experience temporary uncertainty regarding future financial reporting continuity until a new auditor is appointed.
• Management: Responsible for selecting and onboarding a new auditing firm, ensuring a seamless transition.
• Regulatory Authorities: Will monitor the appointment of a new auditor to ensure compliance with SEC regulations and timely financial disclosures.

Next Steps

• Appoint a new independent registered public accounting firm.
• Facilitate a smooth transition with the newly appointed auditor to ensure timely and accurate financial reporting.

Key Dates

Recommendation

The filing primarily concerns a procedural change in the company's independent auditor. While the dismissal of Deloitte & Touche LLP and the absence of an immediate replacement introduce a minor element of uncertainty, the clean audit history with Deloitte for the past two fiscal years and the absence of any disagreements or reportable events mitigate significant concerns. Investors should hold and monitor for the announcement of a new auditor and any subsequent financial reporting updates.

Keywords

KALA BIO, Deloitte & Touche, auditor change, accounting firm, SEC filing, Form 8-K, corporate governance, financial reporting